Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Q2 2026 earnings

Reported August 10, 2026 · Before market open

EPS-$0.55Miss by $0.04
EPS estimate-$0.51

Next report

Nov 11, 2026 (in a month)
EPS estimate-$0.60

FAQ

When did Oruka Therapeutics, Inc. report Q2 2026 earnings?
Oruka Therapeutics, Inc. (ORKA) reported Q2 2026 earnings on August 10, 2026 before market open.
What were Oruka Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Oruka Therapeutics, Inc. reported eps of $-0.55 for Q2 2026.
Did Oruka Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.51 by $0.04.
How did Oruka Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 19.6% from $-0.46.
Where can I find Oruka Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-086933) and the 10-Q periodic report (0001213900-26-087231) directly on SEC EDGAR. The filing index links above go to sec.gov.